U.S. markets open in 1 hour 13 minutes
  • S&P Futures

    3,881.00
    +13.50 (+0.35%)
     
  • Dow Futures

    31,498.00
    +140.00 (+0.45%)
     
  • Nasdaq Futures

    13,100.00
    +44.75 (+0.34%)
     
  • Russell 2000 Futures

    2,246.00
    +16.90 (+0.76%)
     
  • Crude Oil

    60.43
    +0.68 (+1.14%)
     
  • Gold

    1,715.40
    -18.20 (-1.05%)
     
  • Silver

    26.37
    -0.51 (-1.89%)
     
  • EUR/USD

    1.2058
    -0.0029 (-0.24%)
     
  • 10-Yr Bond

    1.4150
    0.0000 (0.00%)
     
  • Vix

    23.30
    -0.05 (-0.21%)
     
  • GBP/USD

    1.3957
    +0.0000 (+0.00%)
     
  • USD/JPY

    106.8520
    +0.1420 (+0.13%)
     
  • BTC-USD

    52,110.90
    +3,303.49 (+6.77%)
     
  • CMC Crypto 200

    1,039.53
    +51.43 (+5.21%)
     
  • FTSE 100

    6,659.84
    +46.09 (+0.70%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

The Zacks Analyst Blog Highlights: Mogo, Rayonier Advanced Materials, HighPoint Resources, Himax Technologies and Aviat Networks

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·5 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

For Immediate Release

Chicago, IL – December 8, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Mogo Inc. MOGO, Rayonier Advanced Materials Inc. RYAM, HighPoint Resources Corp. HPR, Himax Technologies Inc. HIMX and Aviat Networks Inc. AVNW.

Here are highlights from Monday’s Analyst Blog:

5 Market-Beating Top-Ranked Stocks Set to Soar Further

Extending last month’s historic rally, Wall Street has been hitting a series of record highs to start December. The four indices — the S&P 500, the Dow Jones Industrial Average, the tech-heavy Nasdaq Composite and the small-cap Russell 2000 — closed at new highs at the same day for the first time since January 2018, according to Dow Jones Market Data.

The latest rally has been powered by the encouraging development in coronavirus vaccines and hopes of their availability soon. This is especially true as a vaccine will end the economic crisis and result in swift recovery. Additionally, the latest jobs data for November revealed the slowest U.S. jobs growth in six months that has raised expectations for a new fiscal relief bill to help revive the coronavirus-hit economy.

In China, a recent survey revealed that the factory sector accelerated at the fastest pace in a decade in November. This suggests that the world’s second-largest economy has recovered to the pre-pandemic levels. Several other countries also reported sharp upticks in factory activity.

Further, the potential for a divided Congress with President-elect Biden and better-than-expected earnings have been fueling growth in the stocks. A divided government is favorable for the economy, as there will be lesser chances of major tax increases and tighter regulations. The prospect of Biden’s smooth transition to the White House has also been driving the stocks higher.

Given this, we have highlighted five stocks that led the astounding rally over the past month. These stocks have a solid Zacks Rank #1 (Strong Buy) or 2 (Buy) and will continue to outperform to end the year given their superior fundamentals. You can see the complete list of today’s Zacks #1 Rank stocks here.

Mogo – Up 146.3%

This financial technology company provides financial health apps to consumers with solutions to manage and control their finances. It saw a positive earnings estimate revision of 4 cents over the past 30 days for this year and has an estimated earnings growth rate of 43.5%. The stock carries a Zacks Rank #2 and Growth Score of B.

Rayonier Advanced Materials – Up 90.2%

It operates as a global supplier of cellulose specialties products, a natural polymer for the chemical industry. The stock saw a solid earnings estimate revision of 67 cents over the past month for this year and has estimated earnings growth of 91.7%. Rayonier Advanced Materials carries a Zacks Rank #2 and Growth Score of B.

HighPoint Resources – Up 83.4%

This exploration and production company is focused on the development of oil and natural gas assets primarily in the Denver-Julesburg Basin of Colorado. The stock saw a robust earnings estimate revision of $1.25 over the past month for this year and has an estimated earnings growth rate of 167.5%. It has a Zacks Rank #1 and Growth Score of B.

Himax Technologies – Up 80.2%

This company designs, develops and markets semiconductors that are critical components of flat panel displays. The stock saw a positive earnings estimate revision of 8 cents over the past month for this year and has estimated earnings growth of 457.1%. Himax Technologies has a Zacks Rank #2 and Growth Score of A.

Aviat Networks – Up 76.9%

This company is a global supplier of wireless network solutions and network management software, backed by a suite of professional services and support. It saw a positive earnings estimate revision of 45 cents in a month for the fiscal year (ending June 2021). The company has estimated earnings growth of 95.4%. The stock has a Zacks Rank #1 and Growth Score of A.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                          

 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Himax Technologies, Inc. (HIMX) : Free Stock Analysis Report
 
Aviat Networks, Inc. (AVNW) : Free Stock Analysis Report
 
Rayonier Advanced Materials Inc. (RYAM) : Free Stock Analysis Report
 
Mogo Inc (MOGO) : Free Stock Analysis Report
 
HIGHPOINT RESOURCES CORP (HPR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research